AGNC Investment's More Than 13.5% Yield Faces Fed Headwinds
AGNC Investment's more than 13.5% yield looks tempting, especially in a low-rate world. Yet looming Fed rate changes ...
Why Choose Points Over Cash Rebates
Choosing points over cash rebates can lead to greater rewards, especially for travel enthusiasts. Find out why this option is beneficial.
27,389 articles
Lionel Richie’s Ex-Wife Says He’s OK After Health Scare
A high-profile health scare on stage sparked a ripple of financial questions for touring acts and self-employed profe...
McCormick Shifting From Spice to Fridge: A $45 Billion Deal
A 137-year-old spice company bets on a broader food portfolio with Unilever’s iconic brands. This deep dive explains ...
Spacemobile Nears Commercial Launch: Is It Time to Buy?
As spacemobile nears commercial launch, investors wonder if this space-based cellular plan can disrupt the market. Th...
That Replaced Entire Bond: A High-Yield ETF Breakout
A single high-yield ETF is emerging as a practical substitute for traditional bond portfolios, delivering monthly inc...
Stock Market Today: March 2 Rise on $10M World View Deal
On March 2, Ondas surged on news of a $10 million strategic investment and a World View defense partnership. This art...
Aerospace Stock Popped Today: What Fueled the Rally
A strong flight milestone sparked a notable rally in an aerospace company. This guide breaks down the drivers, what i...
After Years Watching Volatility: 3 Utility ETFs for Income
As volatility tests investors, three utility ETFs offer steady income with defensive exposure. Here’s how XLU, VPU, a...
Where Will Rare Earth Stocks Go in 5 Years: USA Outlook
Investing in rare earths sits at the intersection of policy, manufacturing demand, and new mining projects. This guid...
Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Alphabet Owns Million Shares: A Deep Dive Into Space Stock
Alphabet’s investment arm quietly backs high-growth ventures. This deep dive explains why Alphabet owns million share...
XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status